GamaMabs Pharma is Drug Discovery in France that focus on monoclonal antibodies business. Founded in 2013. They cover business area such as developer, optimize therapeutic antibody, cancer, tumor cell kill property, anti-mullerian human receptor, physician, unaddressed specific target.
2013
( 11 years old in 2024 )
Monoclonal Antibodies
-
Centre Pierre Potier, 1 place Pierre Potier
ONCOPOLE entrée B, Cedex 1
50624 Toulouse
France
Private
developeroptimize therapeutic antibodycancertumor cell kill propertyanti-mullerian human receptorphysicianunaddressed specific target
* We use standard office opening hours in near GamaMabs Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
GamaMabs Pharma is Drug Discovery business from France that founded in 2013 (11 years old in 2024), GamaMabs Pharma business is focusing on Monoclonal Antibodies.
GamaMabs Pharma headquarter office and corporate office address is located in Centre Pierre Potier, 1 place Pierre Potier ONCOPOLE entrée B, Cedex 1 50624 Toulouse France.
GamaMabs Pharma was founded in France.
In 2024, GamaMabs Pharma is currently focus on monoclonal antibodies sector.
Above is snippet of Google Trends for "monoclonal antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with GamaMabs Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
